From: miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease
NCI (n = 102) | AD (n = 177) | Total (n = 702) | P value b | |
---|---|---|---|---|
Female | 54 (52.9) | 126 (71.2) | 449 (64.1) | 0.002 |
Age at death in years a | 85.0 (78.8–89.0) | 90.0 (87.4–90.0) | 88.5 (84.1–90.0) | < 0.001 |
Study | ||||
ROS | 53 (52.0) | 93 (52.5) | 381 (54.4) | |
MAP | 49 (48.0) | 84 (47.5) | 320 (45.6) | 0.926 |
Global cognitive Z scores at the last visit a | 0.10 (-0.25–0.36) | -0.35 (-0.93–0.06) | -0.17 (-0.56–0.19) | < 0.001 |
Slope of global cognitive Z scores a | -0.03 (-0.13 – 0.02) | -0.17 (-0.30 – -0.08) | -0.09 (-0.22 – -0.01) | < 0.001 |
RNA integrity numbers a | 7.3 (6.0–8.0) | 6.7 (5.4–7.4) | 6.9 (5.6–7.7) | 0.001 |
Post-mortem interval in hours a | 6.3 (4.8–8.6) | 5.8 (4.2–8.3) | 5.8 (4.3–8.5) | 0.124 |